2025-05-31

Table of Contents

  1. Introduction
  2. Global Market Overview
  3. Leading Antigen Rapid Test Kit Manufacturers
    1. Roche
    2. Abbott Laboratories
    3. Quidel Corporation
    4. Siemens Healthineers
    5. Becton Dickinson and Company
    6. Thermo Fisher Scientific
  4. Immuno Company Solutions
  5. Conclusion
  6. References

Introduction

The antigen rapid test kit market has seen significant growth, driven by the need for efficient and rapid testing methods during health crises like the COVID-19 pandemic. Industry leaders have emerged as key players in delivering solutions tailored for quick diagnostics.

Global Market Overview

The global antigen rapid test kit market size was valued at approximately USD 13.5 billion in 2022. By 2025, the market is projected to reach USD 22.8 billion, growing at a CAGR of 11.3%. This growth is fueled by the increased demand for rapid diagnostics in both developed and developing regions.

Leading Antigen Rapid Test Kit Manufacturers

Roche

Roche is a pioneer in the healthcare industry, providing innovative diagnostics solutions. Its antigen rapid test kits are widely used due to their high specificity and sensitivity, reported at 99% and 96% respectively.

Abbott Laboratories

Abbott Laboratories offers the BinaxNOW rapid test, which is known for delivering results in just 15 minutes with 97.1% sensitivity and 98.5% specificity. Abbott's widespread distribution network has allowed for large-scale accessibility.

Quidel Corporation

Quidel is recognized for its QuickVue antigen tests, catering majorly to the U.S. market. The QuickVue test boasts a sensitivity rate of 96% and a specificity rate of 99%, making it a preferred choice for many institutions.

Siemens Healthineers

Siemens Healthineers manufactures the CLINITEST Rapid COVID-19 Antigen Test, with a reported sensitivity of 96.72% and specificity of 99.22%. Siemens’ strong R&D capabilities contribute to its rapid market uptake.

Becton Dickinson and Company

BD's Veritor System for Rapid Detection of SARS-CoV-2 is known for its ease of use and high throughput capability, attributed to a sensitivity of 84% and specificity of 100%. This makes BD a competitive player in the market.

Thermo Fisher Scientific

Thermo Fisher provides the TaqPath COVID-19 Combined Test Kit, enabling large-scale testing with high accuracy. The solution's sensitivity and specificity stand at 99.7% and 100% respectively, solidifying Thermo Fisher’s status in the industry.

Immuno Company Solutions

Immuno Company is establishing itself as a reliable provider of antigen rapid test kits with a focus on affordability and accuracy. Their tests have shown a sensitivity of 93% and specificity of 98%, and are increasingly becoming popular in regions with budget constraints.

Conclusion

The demand for antigen rapid test kits continues to rise, with leading manufacturers innovating to meet market needs. As the healthcare landscape evolves, these companies are poised to play crucial roles in shaping the future of rapid diagnostics.

References

  • MarketInsightReports. (2023). Global Antigen Rapid Test Market Size.
  • Roche Diagnostics. (2023). Product Specifications for COVID-19 Rapid Antigen Tests.
  • Abbott Laboratories. (2023). BinaxNOW Antigen Test Fact Sheet.
  • Quidel Corporation. (2023). QuickVue SARS Antigen Test Technical Brief.
  • Siemens Healthineers. (2023). CLINITEST Rapid Test Overview.
  • Becton Dickinson and Company. (2023). Veritor System for Rapid Detection.
  • Thermo Fisher Scientific. (2023). TaqPath Combined Test Kit Data Sheet.
  • Immuno Company. (2023). Product Guide and Specifications.
Immuno brand gives you a solution